课题基金 / 基金详情

Detecting the onset of genome heterogeneity in tumor at single cell resolution

Detecting the onset of genome heterogeneity in tumor at single cell resolution
以单细胞分辨率检测肿瘤中基因组异质性的发生
批准号:
8754910
负责人:
Chenghang Zong
金额:
$237.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2019-06-30

项目摘要

项目成果

Chenghang Zong的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): With the emerging evidence of complex tumor heterogeneity, it is critical for us to profile and understand the complex evolution in tumor development. To do so, we desire to characterize the genome heterogeneity and complex evolution at microscopic resolution. Here we propose an exact linear amplification scheme for single cell whole-genome amplification, which will allow us to detect single nucleotide variations (SNVs) with the high accuracy comparable to the bulk sequencing. With this cutting-edge method development, we will be able to profile tumor heterogeneity at single cell resolution with unprecedented accuracy of SNV detection. Our immediate goal in this proposal is to apply this method to discover the onset of heterogeneity at low-grade of neoplasm and the sequential development of genome heterogeneity at the following higher grades of neoplasm. Overall, our goal is to develop a suite of highly promising single cell analytical technologies to gain an understanding of genomic variations in solid cancers. Success of the project will result in an integrated platform that will serve to overcome prevailing impediments in studying clinical samples. The research is expected to have a broad impact on basic research, clinical practice, and the development of therapeutic treatments for early intervention.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Single-cell Damagenome Profiling by Linear Copying and Splitting based Whole Genome Amplification (LCS-WGA)
基于线性复制和分裂的全基因组扩增 (LCS-WGA) 进行单细胞损伤组分析
DOI: 10.21769/bioprotoc.4357
发表时间: 2022
期刊: BIO-PROTOCOL
影响因子: 0.8
作者: [Niu, Yichi, Zhu, Qiangyuan, Zong, Chenghang]
通讯作者: Zong, Chenghang
DOI: 10.1126/sciadv.abf3329
发表时间: 2021-07
期刊: Science Advances
影响因子: 13.6
作者: [Qiangyuan Zhu;Yichi Niu;Michael C. Gundry;Chenghang Zong]
通讯作者: Qiangyuan Zhu;Yichi Niu;Michael C. Gundry;Chenghang Zong
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: